Neuronostics
PrivateLast Round
VC Round
Jun 30, 2026
Total Funding Raised
$7.59M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neuronostics operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a VC Round in June 2026.
Neuronostics is a medical technology company that develops digital biomarkers and software for the diagnosis and prognosis of neurological conditions such as epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuronostics Comparables
Compare Neuronostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Persyst Development Corporation | 79% | |
| AIT Austrian Institute of Technology | 73% | |
| Natus Medical Incorporated | 73% |
For institutional investors. Book with your work email.
Neuronostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 30, 2026 | ||||
| Grant | Sep 4, 2024 | ||||
| Seed | Apr 5, 2024 | ||||
| Grant | Apr 5, 2024 | ||||
| Grant | Apr 5, 2024 | ||||
Pre Seed | Mar 26, 2021 |
For institutional investors. Book with your work email.
Neuronostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Ascension Ventures | VC Round, Seed |
| SBRI Healthcare | Grant |
| QantX | VC Round, Seed, Pre Seed |
| University of Exeter | Corporate Funding, Grant |
| New Wave | VC Round |
| Innovate UK | VC Round, Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
$4M raised from Empirical Ventures and The FSE Group.
- Jun 19, 2026
Monthly visitors increased 87% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 10, 2026
Neuronostics is developing technology that helps improve the diagnosis of and treatment neurological conditions and is recruiting across its science, technical, clinical and commercial teams on Aug 10th '26.
For institutional investors. Book with your work email.
Neuronostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuronostics's valuation, stock price, and market status.
Is Neuronostics a public or private company?
Neuronostics is a private company.
What is the current stock price of Neuronostics?
Neuronostics is a private company, so its shares have no public market price. Caplight tracks Neuronostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuronostics worth (valuation)?
Valuation information for Neuronostics is not publicly available.
Can I buy Neuronostics stock?
Neuronostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuronostics's last funding round?
Neuronostics's most recent funding round was VC Round on June 30, 2026.
Who are the main investors in Neuronostics?
Key investors in Neuronostics include Ascension Ventures, QantX, Empirical Ventures, The FSE Group.
Will Neuronostics IPO soon?
No public IPO plans have been announced for Neuronostics.
How can I track Neuronostics secondary market activity?
Caplight tracks bids, offers, and trades in Neuronostics's shares on secondary markets.